BR9612773A - Processo de modificação. - Google Patents

Processo de modificação.

Info

Publication number
BR9612773A
BR9612773A BR9612773-2A BR9612773A BR9612773A BR 9612773 A BR9612773 A BR 9612773A BR 9612773 A BR9612773 A BR 9612773A BR 9612773 A BR9612773 A BR 9612773A
Authority
BR
Brazil
Prior art keywords
modification process
galactose
mannose
compound containing
vivo
Prior art date
Application number
BR9612773-2A
Other languages
English (en)
Inventor
Morten Jorsboe
Janne Brunstedt
Steen Guldager Petersen
Original Assignee
Danisco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco filed Critical Danisco
Publication of BR9612773A publication Critical patent/BR9612773A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C08B37/0096—Guar, guar gum, guar flour, guaran, i.e. (beta-1,4) linked D-mannose units in the main chain branched with D-galactose units in (alpha-1,6), e.g. from Cyamopsis Tetragonolobus; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Emergency Medicine (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

"PROCESSO DE MODIFICAçãO" Descreve-se um processo de modificação in vivo. O processo de modificação in vivo afeta a proporção de manose para galactose de um organismo (ou parte dele) capaz de produzir um composto que contém manose/galactose ou a de um composto que contém manose/galactose dele derivado.
BR9612773-2A 1995-12-04 1996-12-02 Processo de modificação. BR9612773A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9524752.4A GB9524752D0 (en) 1995-12-04 1995-12-04 Modification process
PCT/EP1996/005581 WO1997020937A2 (en) 1995-12-04 1996-12-02 Modification process

Publications (1)

Publication Number Publication Date
BR9612773A true BR9612773A (pt) 2001-01-02

Family

ID=10784871

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612773-2A BR9612773A (pt) 1995-12-04 1996-12-02 Processo de modificação.

Country Status (8)

Country Link
EP (1) EP0866869A2 (pt)
JP (1) JP2000502252A (pt)
CN (1) CN1207772A (pt)
AU (1) AU1193997A (pt)
BR (1) BR9612773A (pt)
GB (1) GB9524752D0 (pt)
MX (1) MX9804483A (pt)
WO (1) WO1997020937A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6311808B1 (en) 1996-02-09 2001-11-06 Continental Teves Ag & Co., Ohg Combined service and parking brake system
GB9710990D0 (en) * 1997-05-28 1997-07-23 Danisco Modification process
GB9807520D0 (en) * 1998-04-09 1998-06-10 Univ Wales Medicine Modified biological material
GB9810997D0 (en) * 1998-05-21 1998-07-22 Unilever Plc Genes & enzymes
BR9915148A (pt) * 1998-11-11 2001-08-07 Produites Nestle S A Soc D Mananase de coffea arábica
EP1138771A1 (fr) * 2000-03-30 2001-10-04 Societe Des Produits Nestle S.A. Endo-Mannanase de café
RU2363733C2 (ru) * 2001-11-06 2009-08-10 Дзе Юниверсити Оф Бритиш Коламбиа Модуляция деградации мочевины в винных дрожжах
US7265265B2 (en) 2002-11-14 2007-09-04 Pioneer Hi-Bred International, Inc. Genes for galactomannan production in plants and methods of use
JP4960591B2 (ja) * 2004-12-14 2012-06-27 味の素ゼネラルフーヅ株式会社 マンノオリゴ糖類を含有する抗アレルゲン組成物
US7678556B2 (en) 2006-11-21 2010-03-16 Cornell Research Foundation, Inc. Beta-mannanase from coffee berry borer, Hypothenemus hampei, and uses thereof
WO2008112170A1 (en) 2007-03-09 2008-09-18 Corning Incorporated Three dimensional gum matrices for cell culture, manufacturing methods and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153568C (da) * 1985-02-12 1988-12-05 Novo Industri As Alfa-galactomannangalactosidase og middel indeholdende denne
EP0255153B1 (en) * 1986-06-03 1995-01-18 Unilever N.V. Production of guar alpha-galactosidase by hosts transformed by recombinant DNA methods
WO1995007088A1 (en) * 1993-09-08 1995-03-16 New York Blood Center, Inc. RECOMBINANT α-GALACTOSIDASE ENZYME AND cDNA ENCODING SAID ENZYME

Also Published As

Publication number Publication date
CN1207772A (zh) 1999-02-10
MX9804483A (es) 1998-09-30
GB9524752D0 (en) 1996-02-07
WO1997020937A2 (en) 1997-06-12
AU1193997A (en) 1997-06-27
EP0866869A2 (en) 1998-09-30
WO1997020937A3 (en) 1997-11-27
JP2000502252A (ja) 2000-02-29

Similar Documents

Publication Publication Date Title
DE69716767D1 (de) Verfahren zur herstellung von tolterodin
EP0758028A3 (en) Process of producing graphite fiber
AU6760987A (en) Method of treating alzheimer's disease
BR9612773A (pt) Processo de modificação.
BR9612380A (pt) Processo de preparação de catalisadores que comportam pelo menos um metal de transição no grau de oxidação 0 ou 1 pelo menos uma fosfina hidrossolúvel monodentada ou bidentada
CA2147863A1 (en) Determination of peptide motifs on mhc molecules
ES2059501T5 (es) Aminoacidos utiles en trastornos hepaticos.
PT994108E (pt) Processo de producao de derivados de 2-hidroxibenzamida
BR9611339A (pt) Processo de preparação de 1,3-propanediol
FI895389A0 (fi) Foerfarande foer framstaellning av 3,5 -dimetyl-4-metoxipyridinderivat samt ny mellanprodukt haerfoer.
ZA962846B (en) Treatment of traveller's diarrhea
IT1240868B (it) Processo per la produzione di perossido di idrogeno (ii)
WO1997014712A3 (de) Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
CA2200582A1 (en) Dna encoding human papillomavirus type 6a
CA2204384A1 (en) Medicinal composition for diabetes
HUT61035A (en) Process for producing peptide fixing fibronectine
HU9303227D0 (en) D-3 vitamine analogues and process for producing them
BR9006747A (pt) Processo de produzir um pigmento opacificante
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
FR2705666B1 (fr) Procédé de préparation d'une cétone cyclique.
PT719499E (pt) Processo de tratamento anti-germinativo de tuberculos ou bolbos
FR2693473B1 (fr) Procédé de préparation enzymatique d'hydrolysats de matières protéiques.
PL312734A1 (en) Method of production of white micro-silica

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
FA14 Dismissal: dismissal - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]